Doctors at San Francisco General Hospital's famed AIDS clinic have shown the immune system can be primed to keep the virus in ...

Small HIV trials suggest combinations of immune therapies may help some people control the virus without daily medication, although larger studies and sustained funding are still needed.

SHELTON, CT / ACCESS Newswire / October 5, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

Four pathogens account for most infection-related cancers, a new study highlights, but the tools to prevent them range from ...

Detailed price information for Nanoviricides Inc (NNVC-A) from The Globe and Mail including charting and trades.

With federal vaccine policy and infectious disease research undergoing major changes, professional medical societies are stepping in to fill gaps once occupied by federal health agencies. In a ...

A similarity between the viruses behind the flu and HIV is now the subject of a research effort at Michigan State University that could help develop effective vaccines for both of them.

NIH has awarded its Director's Pioneer Award to Sylvester Comprehensive Cancer Center virologist Leor Weinberger for ...

Lenacapavir is a long-acting antiretroviral medicine that has introduced a fundamentally different approach to HIV prevention ...

It isn’t always easy to know what to believe when it comes to cancer. In part 2 of a Daily Maverick and Spotlight special ...

Nucleoside analogs show protective and therapeutic effects in a mouse model of multiple sclerosis (MS) and association with reduced MS risk in humans.